Therapy of advanced acute myeloblastic leukemia with cytarabine and interleukin 2

The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma.

1986 • 492 citations

Relapse of acute leukemia after marrow transplantation: natural history and results of subsequent therapy.

1989 • 172 citations

Interleukin-2 induction of lymphokine-activated killer (LAK) activity in the peripheral blood and bone marrow of acute leukemia patients: II. Feasibility of LAK generation in children with active disease and in remission

1989 • 162 citations

In vitro and in vivo susceptibility of human leukemic cells to lymphokine activated killer activity.

1988 • 96 citations

Effects of recombinant interleukin-2 administration on cytotoxic function following high-dose chemo-radiotherapy for hematological malignancy

1989 • 93 citations

Induction and Persistence of Complete Remission in a Resistant Acute Myeloid Leukemia Patient after Treatment with Recombinant Interleukin-2

1990 • 42 citations

Acute myeloid leukaemia relapsing following interleukin‐2 treatment expresses the alpha chain of the interleukin‐2 receptor

1991 • 31 citations

Comparison of chemotherapy with immunotherapy for maintenance of acute lymphoblastic leukemia in children and adults

1983 • 25 citations

Comparison of chemotherapy with immunotherapy for maintenance of acute lymphoblastic leukemia in children and adults

1983 • 20 citations

A sensitive test for the detection of NK activity

1988 • 17 citations

Assay of lymphokine-activated killer activity generated from bone marrow cells of children with acute lymphoblastic leukemia

1990 • 8 citations

Cited By (0)

Loading...